P
23.32
0.42 (1.83%)
| Previous Close | 22.90 |
| Open | 23.14 |
| Volume | 348,471 |
| Avg. Volume (3M) | 819,927 |
| Market Cap | 2,829,019,136 |
| Price / Earnings (TTM) | 212.00 |
| Price / Earnings (Forward) | 44.25 |
| Price / Sales | 1.68 |
| Price / Book | 4.43 |
| 52 Weeks Range | |
| Earnings Date | 8 May 2025 |
| Profit Margin | 0.83% |
| Operating Margin (TTM) | 1.14% |
| Diluted EPS (TTM) | 0.110 |
| Quarterly Revenue Growth (YOY) | 4.60% |
| Quarterly Earnings Growth (YOY) | 55.00% |
| Total Debt/Equity (MRQ) | 0.82% |
| Current Ratio (MRQ) | 1.86 |
| Operating Cash Flow (TTM) | 109.28 M |
| Levered Free Cash Flow (TTM) | 104.86 M |
| Return on Assets (TTM) | 0.99% |
| Return on Equity (TTM) | 2.64% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Privia Health Group, Inc. | Bearish | Bullish |
AIStockmoo Score
-0.8
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | -1.5 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | 0.5 |
| Average | -0.75 |
|
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 6.75% |
| % Held by Institutions | 101.49% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rubicon Founders Llc | 31 Dec 2024 | 5,773,522 |
| Van Berkom & Associates Inc. | 31 Mar 2025 | 2,013,672 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 40.00 (Piper Sandler, 71.53%) | Buy |
| Median | 29.00 (24.36%) | |
| Low | 23.00 (Barclays, -1.37%) | Hold |
| Average | 29.38 (25.99%) | |
| Total | 7 Buy, 1 Hold | |
| Avg. Price @ Call | 24.16 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JMP Securities | 28 Apr 2025 | 29.00 (24.36%) | Buy | 23.20 |
| 14 Feb 2025 | 26.00 (11.49%) | Buy | 25.24 | |
| Baird | 15 Apr 2025 | 26.00 (11.49%) | Buy | 24.19 |
| Barclays | 10 Apr 2025 | 23.00 (-1.37%) | Hold | 23.65 |
| Needham | 10 Apr 2025 | 30.00 (28.64%) | Buy | 23.65 |
| 21 Mar 2025 | 30.00 (28.64%) | Buy | 23.34 | |
| Truist Securities | 10 Apr 2025 | 28.00 (20.07%) | Buy | 23.65 |
| Canaccord Genuity | 28 Feb 2025 | 30.00 (28.64%) | Buy | 24.97 |
| Citizens Capital Markets | 28 Feb 2025 | 29.00 (24.36%) | Buy | 24.97 |
| Piper Sandler | 28 Feb 2025 | 40.00 (71.53%) | Buy | 24.97 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 08 May 2025 | Announcement | Privia Health Reports First Quarter 2025 Financial Results |
| 09 Apr 2025 | Announcement | Privia Health Enters Arizona In Partnership with Integrated Medical Services |
| 08 Apr 2025 | Announcement | Privia Health to Report First Quarter 2025 Results on Thursday, May 8 |
| 27 Feb 2025 | Announcement | Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |